Shiva Amiri
Private Equity Investor bei Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd.
Profil
Shiva Amiri is currently the Vice President and Head of AI & Data Intelligence at Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd.
She previously worked as the Chief Executive Officer at BioSymetrics, Inc. from 2016 to 2017 and as a Director at Zymergen, Inc. from 2018 to 2022.
Dr. Amiri holds a doctorate degree from the University of Oxford, which she received in 2006, and an undergraduate degree from the University of Toronto, which she received in 2003.
Aktive Positionen von Shiva Amiri
Unternehmen | Position | Beginn |
---|---|---|
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Private Equity Investor | 01.09.2022 |
Ehemalige bekannte Positionen von Shiva Amiri
Unternehmen | Position | Ende |
---|---|---|
ZYMERGEN INC. | Corporate Officer/Principal | 01.09.2022 |
BioSymetrics, Inc.
BioSymetrics, Inc. Packaged SoftwareTechnology Services BioSymetrics, Inc. develops an artificial intelligence and machine learning data science software solutions. It offers a SaaS-based biomedical Machine Learning (ML) platform, Augusta, that enables customers to perform automated ML and data pre-processing. Augusta?s automated iteration framework addresses the step in ML that is time consuming and error-prone, that of cleaning and pre-processing unstructured data for analysis. The company was founded by Anthony Iacovone in 2015 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.09.2017 |
Ausbildung von Shiva Amiri
University of Oxford | Doctorate Degree |
University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
BioSymetrics, Inc.
BioSymetrics, Inc. Packaged SoftwareTechnology Services BioSymetrics, Inc. develops an artificial intelligence and machine learning data science software solutions. It offers a SaaS-based biomedical Machine Learning (ML) platform, Augusta, that enables customers to perform automated ML and data pre-processing. Augusta?s automated iteration framework addresses the step in ML that is time consuming and error-prone, that of cleaning and pre-processing unstructured data for analysis. The company was founded by Anthony Iacovone in 2015 and is headquartered in Toronto, Canada. | Technology Services |
Zymergen, Inc.
Zymergen, Inc. Miscellaneous Commercial ServicesCommercial Services Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. Its products include electronic films, repellent products, and agriculture products such as traditional synthetic nitrogen fertilizers and traditional chemical-based crop protection products. The company was founded by Zachariah Serber, Jed Dean and Joshua J. Hoffman in 2013 and is headquartered in Emeryville, CA. | Commercial Services |
Pivotal Bioventure Partners China Advisor (Beijing) Co. Ltd. | Finance |